|
Feb 20
|
Vistagen to Participate in the 45th Annual TD Cowen Healthcare Conference
|
|
Feb 15
|
Vistagen Therapeutics Third Quarter 2025 Earnings: Beats Expectations
|
|
Feb 14
|
Vistagen Therapeutics Inc (VTGN) Q3 2025 Earnings Call Highlights: Promising Trial Results and ...
|
|
Feb 13
|
VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates
|
|
Feb 13
|
Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update
|
|
Feb 12
|
Companies Like Vistagen Therapeutics (NASDAQ:VTGN) Are In A Position To Invest In Growth
|
|
Oct 11
|
VistaGen Therapeutics (VTGN) Upgraded to Buy: Here's What You Should Know
|
|
Oct 9
|
Vistagen Therapeutics Inc (VTGN) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges
|
|
Oct 9
|
Vistagen, The Goldie Hawn Foundation, and MindUP Students to Ring Nasdaq Closing Bell on World Mental Health Day
|
|
Sep 24
|
Vistagen enrols first subject in Phase III trial of social anxiety disorder drug
|
|
Aug 13
|
VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Lags Revenue Estimates
|
|
Jun 27
|
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
|
|
Jun 12
|
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript
|
|
Jun 11
|
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
|
|
Jun 7
|
Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024
|
|
May 29
|
Vistagen to Present at the Jefferies Global Healthcare Conference
|
|
May 7
|
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
|
|
Apr 25
|
Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
|
|
Apr 19
|
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
|
|
Apr 9
|
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
|